Invesco Ltd. Aptinyx Inc. Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 17, 2021
SELL
$2.39 - $3.5 $47,142 - $69,037
-19,725 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$2.86 - $4.33 $2,797 - $4,234
978 Added 5.22%
19,725 $59,000
Q4 2020

Feb 16, 2021
BUY
$2.93 - $4.3 $54,928 - $80,612
18,747 New
18,747 $65,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email